logo

Last Update

This profile was last updated on 8/17/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Mark Prausnitz?

Mark R. Prausnitz

Professor of Chemical and Biomedical Engineering

Georgia Institute of Technology

HQ Phone:  (404) 894-2000

Direct Phone: (404) ***-****direct phone

Email: p***@***.edu

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Georgia Institute of Technology

901 Atlantic Drive

Atlanta, Georgia,30332

United States

Company Description

The Georgia Institute of Technology is ranked among the nation's top 10 public universities (U.S. News and World Report), providing a focused, technology based education to more than 25,000 undergraduate and graduate students. As a leading technological resear...more

Web References(183 Total References)


CRS Nominations

www.controlledreleasesociety.org [cached]

Mark Prausnitz


Leadership - 4P THERAPEUTICS - Transdermal Research and Development

www.4ptherapeutics.com [cached]

Mark Prausnitz- Ph.D.
Dr. Mark Prausnitz is currently Love Family Professor in Chemical & Biomolecular Engineering, and Director of the Center for Drug Design, Development and Delivery at Georgia Institute of Technology. Dr. Prausnitz and his colleagues carry out research on biophysical methods of drug delivery, which employ microneedles, ultrasound, lasers, electric fields, heat, convective forces and other physical means to control the transport of drugs, proteins, genes and vaccines into and within the body. In collaboration with Emory University, the Centers for Disease Control and Prevention and other organizations, Dr. Prausnitz's group is advancing microneedles from device design and fabrication through pharmaceutical formulation and pre-clinical animal studies through studies in human subjects. In addition to developing a self-administered influenza vaccine using microneedles, Dr. Prausnitz is translating microneedles technology especially to make vaccination in developing countries more effective. Dr. Prausnitz received his B.S. in 1988 from Stanford University and his Ph.D. in 1994 from Massachusetts Institute of Technology.


Board of Directors | Clearside Biomedical

clearsidebio.com [cached]

Mark R. Prausnitz, Ph.D - Board Member
Regents' Professor of Chemical and Biomedical Engineering, Georgia Institute of Technology Mark Prausnitz is Regents' Professor of Chemical and Biomedical Engineering, Love Family Professor of Chemical & Biomolecular Engineering, and Director of the Center for Drug Design, Development and Delivery at the Georgia Institute of Technology. His research interests focus on biophysical methods of drug delivery, which employ microfabricated devices, microneedles, ultrasound, lasers, electric fields and other physical means to control the transport of drugs, proteins, genes and vaccines into and within the body. Dr. Prausnitz earned a B.S. degree from Stanford University and a Ph.D. degree from the Massachusetts Institute of Technology, both in chemical engineering. He worked for one year at Alza Corporation carrying out research on transdermal drug delivery systems and for one year at ORBIS International teaching biomedical engineering in developing country hospitals. He has co-founded three start-up companies, most recently Clearside Biomedical. At Georgia Tech, Dr. Prausnitz teaches an introductory course on engineering calculations, as well as two advanced courses on pharmaceuticals and technical communication, both of which he developed. He also serves the broader scientific and business communities as a frequent consultant, advisory board member and expert witness. Dr. Prausnitz has published more than 160 research articles, delivered over 150 invited lectures at conferences, universities and companies, filed 35 issued or pending patents and supervised more than 30 doctoral theses.


Scientific Founders | Clearside Biomedical

clearsidebio.com [cached]

Mark Prausnitz, Ph.D, Regents' Professor of Chemical and Biomedical Engineering, Georgia Institute of Technology
Mark Prausnitz is Regents' Professor of Chemical and Biomedical Engineering, Love Family Professor of Chemical & Biomolecular Engineering, and Director of the Center for Drug Design, Development and Delivery at the Georgia Institute of Technology. His research interests focus on biophysical methods of drug delivery, which employ microfabricated devices, microneedles, ultrasound, lasers, electric fields and other physical means to control the transport of drugs, proteins, genes and vaccines into and within the body. Dr. Prausnitz earned a B.S. degree from Stanford University and a Ph.D. degree from the Massachusetts Institute of Technology, both in chemical engineering. He worked for one year at Alza Corporation carrying out research on transdermal drug delivery systems and for one year at ORBIS International teaching biomedical engineering in developing country hospitals. He has co-founded three start-up companies, most recently Clearside Biomedical, Inc. At Georgia Tech, Dr. Prausnitz teaches an introductory course on engineering calculations, as well as two advanced courses on pharmaceuticals and technical communication, both of which he developed. He also serves the broader scientific and business communities as a frequent consultant, advisory board member and expert witness. Dr. Prausnitz has published more than 160 research articles, delivered over 150 invited lectures at conferences, universities and companies, filed 35 issued or pending patents and supervised more than 30 doctoral theses. Dr. Patel completed his doctoral degree in chemical and biomolecular engineering from the Georgia Institute of Technology in the drug delivery lab of Dr. Mark Prausnitz.


SBE - Leadership

www.aiche.org [cached]

Professor Mark Prausnitz, Georgia Institute of Technology


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory